BioSpace News Archive

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced that management will participate in the following virtual investor conferences in June: Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021; fireside chat at 11:00 a.m. ET

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced the appointment of Alex Kelly as Chief Financial Officer. Alex joined Precision BioSciences in October 2020 as Chief Corporate Affairs Officer and has served as the company’s Interim Chief Financial Officer

Tarus Therapeutics Inc., an innovative biotechnology company developing adenosine receptor antagonists for cancer immunotherapy, today announced that it has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to proceed with a clinical study of TT-4, an oral small molecule drug targeting the Adenosine A2B receptor (A2BR).

MediPines is pleased to announce that their AGM100 device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence Awards.

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, announced today that Chris Martin, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021, at 8:30 a.m. ET.

TG Therapeutics, Inc. announced its participation at three upcoming virtual investor conferences.

Research includes innovations in lipid nanoparticle technology for mRNA delivery into hematopoietic stem and progenitor cells Intracellular event-guided rational design of lipid nanoparticle Assessment and prediction of SARS-CoV-2 variants for selection of COVID-19 booster vaccines

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 3, 2021 at 4:30 p.m. ET.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:30 a.m. ET.

Mereo BioPharma Group plc, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Thursday, June 3, 2021 at 8:00am Eastern Time.